Affordable Access

deepdyve-link
Publisher Website

Decreasing Opioid Use Postpartum: A Quality Improvement Initiative.

Authors
  • Rogers, Rebecca G1
  • Nix, Michael
  • Chipman, Zachary
  • Breen, Michael
  • Dieterichs, Chad
  • Nutt, Stephanie
  • Moxham, Jamie
  • Chang, Patrick
  • Rathouz, Paul J
  • Robertson, Henry
  • Young, Amy
  • 1 Departments of Women's Health, Surgery and Perioperative Care, and Population Health, Dell Medical School, University of Texas at Austin, and Analytics and Health Economics, Seton Healthcare Family, Austin, Texas.
Type
Published Article
Journal
Obstetrics and gynecology
Publication Date
Nov 01, 2019
Volume
134
Issue
5
Pages
932–940
Identifiers
DOI: 10.1097/AOG.0000000000003512
PMID: 31599842
Source
Medline
Language
English
License
Unknown

Abstract

To estimate the effects of an inpatient initiative to decrease opioid use among women admitted to labor and delivery. We created a multimodal pain power plan with standard therapeutic postpartum activity goals rather than pain goals, tiered order sets with scheduled administration of nonsteroidal antiinflammatory drugs (NSAIDs), and embedded changes into the electronic health record. Before the multimodal pain power plan launch, pain was assessed on a 10-point scale; women received NSAIDs for pain levels of 3 or less and opioids for pain levels higher than 3. For this analysis, we included women who delivered at 5 hospitals in the 10 months before and 12 months after the multimodal pain power plan launch. Women with prior substance use disorder or complicated deliveries were excluded and we stratified analyses into women who delivered vaginally compared with by cesarean. Opioid use was converted to morphine milligram equivalent (MME). Women rated pain control in 24-hour blocks using individually ascertained cutoffs. A multivariable regression analysis was performed, and adjusted odds ratios are reported. We compared the 6,892 women who delivered 10 months before the pain power plan launch to the 7,527 who delivered in the 12 months after the launch. The mean cohort age was 29.6±6.0 years; the majority (75%) were white. Risk of opioid use decreased by 26% among women who delivered vaginally (risk ratio [RR] 0.74; 95% CI [0.68, 0.81]) and 18% among women who delivered by cesarean (RR 0.82; 95% CI [0.72, 0.92]). Among women who received opioids, mean MME use decreased 21% (RR 0.79; 95% CI [0.70, 0.88]) and 54% (RR 0.46; 95% CI [0.35, 0.61]) in the vaginal and cesarean delivery groups, respectively. Fewer women reported acceptable pain levels, with decreases of 82-69% (P<.01) and 82-74% (P<.01) in the vaginal and cesarean delivery groups, respectively. Within the postlaunch cesarean delivery group, women also reported that they were less likely to have their pain well controlled on the Hospital Consumer Assessment of Healthcare Providers and Systems questionnaires (82% vs 62%, P <.01). A standardized multimodal pain power plan reduced opioid use among a large cohort of women admitted to labor and delivery in Central Texas. Despite meeting functional goals, some women reported increased pain during their hospital stay.

Report this publication

Statistics

Seen <100 times